Investor profile
BioGeneration Ventures has backed 9 European tech companies across 10 funding rounds between 2014 and 2026, joining rounds totalling €339M. Most active in Healthtech. Data as of 20 Sept 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Citryll | Netherlands | 2 | €104M |
| Complement Therapeutics | Germany | 1 | €72M |
| CatalYm | Germany | 1 | €50M |
| Mironid | UK | 1 | €40M |
| Confo Therapeutics | Belgium |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Citryll | Series B | €85M | 2024-12 |
| Complement Therapeutics | Series A | €72M | 2023-04 |
| CatalYm | Series C | €50M | 2022-11 |
| Confo Therapeutics |
| 1 |
| €30M |
| Scenic Biotech | Netherlands | 1 | €28M |
| FundaMental Pharma | Germany | 1 | €10M |
| Cristal Therapeutics | Netherlands | 1 | €6.0M |
| Phosphoenix | Netherlands | 1 | €0 |
| Series A |
| €30M |
| 2019-04 |
| Scenic Biotech | Series A | €28M | 2022-03 |
| Citryll | Other | €19M | 2020-02 |
| FundaMental Pharma | Seed | €10M | 2022-11 |
| Cristal Therapeutics | Early VC | €6.0M | 2014-12 |
